Company: BNBX
Filing Date: 2025-01-10
Form Type: S-1/A
Source: 0001104659-25-002521
Chunk: 43

Company: BNB PLUS CORP.
Filing Date: 2025-01-10
Form: S-1/A
Chunk 43
---

of January 8, 2025, there were 107,243 shares of Common Stock issuable upon exercise of options outstanding, 91,791,191 shares of Common
Stock issuable upon exercise of warrants outstanding, and 270,002 shares of Common Stock reserved for future grant or issuance. The authorized
and unissued shares of Common Stock and preferred stock are available for issuance without further action by our stockholders.

Common Stock

Each stockholder of our Common Stock is entitled
to one vote for each share issued and outstanding held on all matters to be voted upon by the stockholders. Our shares of Common Stock
have no preemptive, conversion, or redemption rights. The rights, preferences, and privileges of the holders of Common Stock are subject
to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock. Upon the sale of substantially
all of our stock or assets or dissolution, liquidation or winding up, and after all liquidation preferences payable to any series of
preferred stock entitled thereto have been satisfied, our remaining assets shall be distributed to all holders of Common Stock and any
similarly situated stockholders who are not entitled to any liquidation preference or, if there be an insufficient amount to pay all
such stockholders, then ratably among such holders. All of our issued and outstanding shares of Common Stock are fully paid and non-assessable.
The holders of shares of our Common Stock will be entitled to such cash dividends as may be declared from time to time by our Board of
Directors from funds available therefor.

Our Common Stock is listed the Nasdaq Capital
Market under the symbol “APDN.” The transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. The
transfer agent and registrar’s address is 90 Park Avenue, New York, NY 10016.

Private Placement Warrants

Duration and Exercise Price

Each Private Placement Warrant has an exercise
price of $0.32 per share of Common Stock and will become exercisable upon the Stockholder Approval Date. The Series C Warrants will
expire on the five-year anniversary of the Stockholder Approval Date, the Series D Warrants will expire on the 18-month anniversary
of the Stockholder Approval Date and the Placement Agent Warrants will expire on October 30, 2029.

Exercisability

The Private Placement Warrants are exercisable,
at the option of each holder, in whole or in part